ImmuSAFE is able to determine titre and position of antibodies.

Figure 1: Overall breadth of epitope coverage in all 50 cases. All positive samples showed antibody reactivity towards at least 1 domain and displayed diverse locality distribution. The numerical value in each red dot represents the number of total antigens with positive antibody reactivity.
ImmuSAFE data shows that antibody coverage and titre increases with age.

Figure 2: A positive correlation between increasing age of COVID-19 patients and higher Epitope Coverage scores (EPC) was observed. The figure on the bar plot represents the average number of antigens with positive immunoreactivity exhibited by each age group.

Figure 3: A positive correlation was evident between COVID-19 patients aged above 40 and antibody titre towards SARS-CoV-2 N antigens